Little is known about the association of Toxoplasma gondii infection and neurological disorders. We performed a case-control study with 344 patients with neurological diseases and 344 neurologically healthy age- and gender-matched subjects. Sera of participants were analyzed for anti-T. gondii IgG and IgM antibodies using commercially available immunoassays. Anti-T. gondii IgG antibodies were detected in 25 (7.3%) cases and in 35 (10.2%) controls (odds ratio [OR] = 0.69; 95% confidence interval [CI]: 0.40–1.18; P = 0.17). Anti-T. gondii IgM antibodies were found in 5 (14.3%) of the 25 IgG seropositive cases and in 13 (37.1%) of the 35 IgG seropositive controls (P = 0.15). Anti-T. gondii IgG antibodies were found in 8 (3.8%) of 213 female cases and in 23 (10.8%) of 213 female controls (OR = 0.32; 95% CI: 0.14–0.73; P = 0.005); and in 17 (13.0%) of 131 male cases and in 12 (9.2%) of 131 male controls (P = 0.32). No direct association between IgG seropositivity and specific neurological disorders was detected. We found no support for a role of latent T. gondii infection in the risk for neurological disorders in this setting. With respect to specific neurological disorders, further studies using larger patient cohorts will be required.
Meireles LR , Ekman CC, Andrade JR HF, Luna EJ: Human toxoplasmosis outbreaks and the agent infecting form. findings from a systematic review. Rev Inst Med Trop Sao Paulo 57, 369–376 (2015)
Schlüter D , Däubener W, Schares G, Groß U, Pleyer U, Lüder C: Animals are key to human toxoplasmosis. Int J Med Microbiol 304, 917–929 (2014)
Derouin F , Pelloux H; ESCMID Study Group on Clinical Parasitology: Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect 14, 1089–1101 (2008)
Alvarado-Esquivel C , Liesenfeld O, Márquez-Conde JA, Estrada-Martínez S, Dubey JP: Seroepidemiology of infection with Toxoplasma gondii in workers occupationally exposed to water, sewage, and soil in Durango, Mexico. J Parasitol 96, 847–850 (2010)
Montoya JG , Liesenfeld O: Toxoplasmosis. Lancet 363, 1965–1976 (2004)
Wong WK , Upton A, Thomas MG: Neuropsychiatric symptoms are common in immunocompetent adult patients with Toxoplasma gondii acute lymphadenitis. Scand J Infect Dis 45, 357–361 (2013)
Machala L , Kodym P, Malý M, Geleneky M, Beran O, Jilich D: Toxoplasmosis in immunocompromised patients. Epidemiol Mikrobiol Imunol 64, 59–65 (2015)
McAuley JB : Congenital toxoplasmosis. J Pediatric Infect Dis Soc 3 Suppl 1, S30–35 (2014)
Ueno N , Lodoen MB: From the blood to the brain: avenues of eukaryotic pathogen dissemination to the central nervous system. Curr Opin Microbiol 26, 53–59 (2015)
Harker KS , Ueno N, Lodoen MB: Toxoplasma gondii dissemination: a parasite’s journey through the infected host. Parasite Immunol 37, 141–149 (2015)
McConkey GA , Martin HL, Bristow GC, Webster JP: Toxo plasma gondii infection and behaviour – location, location, location? J Exp Biol 216, 113–119 (2013)
Parlog A , Harsan LA, Zagrebelsky M, Weller M, von Elverfeldt D, Mawrin C, Korte M, Dunay IR: Chronic murine toxoplasmosis is defined by subtle changes in neuronal connectivity. Dis Model Mech 7, 459–469 (2014)
Kamerkar S , Davis PH: Toxoplasma on the brain: understanding host-pathogen interactions in chronic CNS infection. J Parasitol Res 2012, 589295 (2012)
Blanchard N , Dunay IR, Schlüter D: Persistence of Toxoplasma gondii in the central nervous system: a fine-tuned balance between the parasite, the brain and the immune system. Parasite Immunol 37, 150–158 (2015)
Parlog A , Schlüter D, Dunay IR: Toxoplasma gondiiinduced neuronal alterations. Parasite Immunol 37, 159–170 (2015)
Klein RS , Garber C, Howard N: Infectious immunity in the central nervous system and brain function. Nat Immunol 18, 132–141 (2017)
Dubey JP , Lago EG, Gennari SM, Su C, Jones JL: Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology 139, 1375–1424 (2012)
Bachmann S , Schröder J, Bottmer C, Torrey EF, Yolken RH: Psychopathology in first-episode schizophrenia and antibodies to Toxoplasma gondii. Psychopathology 38, 87–90 (2005)
Alvarado-Esquivel C , Urbina-Álvarez JD, Estrada-Martínez S, Torres-Castorena A, Molotla-de-León G, Liesenfeld O, Dubey JP: Toxoplasma gondii infection and schizophrenia: a case control study in a low Toxoplasma se ro prevalence Mexican population. Parasitol Int 60, 151–155 (2011)
Alvarado-Esquivel C , Sanchez-Anguiano LF, Hernandez-Tinoco J, Berumen-Segovia LO, Torres-Prieto YE, Estrada-Martinez S, Perez-Alamos AR, Ortiz-Jurado MN, Molotla-de-Leon G, Beristain Garcia I, Rabago-Sanchez E, Liesenfeld O: Toxoplasma gondii infection and mixed anxiety and depressive disorder: a case-control seroprevalence study in Durango, Mexico. J Clin Med Res 8, 519–523 (2016)
Hinze-Selch D , Däubener W, Erdag S, Wilms S: The diagnosis of a personality disorder increases the likelihood for seropositivity to Toxoplasma gondii in psychiatric patients. Folia Parasitol (Praha) 57, 129–135 (2010)
Miman O , Mutlu EA, Ozcan O, Atambay M, Karlidag R, Unal S: Is there any role of Toxoplasma gondii in the etiology of obsessive-compulsive disorder? Psychiatry Res 177, 263–265 (2010)
Flegr J , Escudero DQ: Impaired health status and increased incidence of diseases in Toxoplasma-seropositive subjects – an explorative cross-sectional study. Parasitology 143, 1974–1989 (2016)
Shanmugam J , Naseema K, Sarada C, Rout D: Toxoplasma gondii IgM antibody prevalence study in patients suffering from neurological disorders. Indian J Pathol Microbiol 38, 423–426 (1995)
Alvarado-Esquivel C , Pacheco-Vega SJ, Hernández-Tinoco J, Salcedo-Jáquez M, Sánchez-Anguiano LF, Berumen-Segovia LO, Rábago-Sánchez E, Liesenfeld O: Toxoplasma gondii infection in interstate truck drivers: a case-control seroprevalence study. Parasit Vectors 8, 77 (2015)
Beltrame A , Venturini S, Crichiutti G, Meroni V, Buonfrate D, Bassetti M: Recurrent seizures during acute acquired toxoplasmosis in an immunocompetent traveler returning from Africa. Infection 44, 259–262 (2016)
Ngoungou EB , Bhalla D, Nzoghe A, Dardé ML, Preux PM: Toxoplasmosis and epilepsy – systematic review and metaanalysis. PLoS Negl Trop Dis 9, e0003525 (2015)
Miman O , Kusbeci OY, Aktepe OC, Cetinkaya Z: The probable relation between Toxoplasma gondii and Parkinson’s disease. Neurosci Lett 475, 129–131 (2010)
Kusbeci OY , Miman O, Yaman M, Aktepe OC, Yazar S: Could Toxoplasma gondii have any role in Alzheimer disease? Alzheimer Dis Assoc Disord 25, 1–3 (2011)
Celik T , Kamişli O, Babür C, Cevik MO, Oztuna D, Altinayar S: Is there a relationship between Toxoplasma gondii infection and idiopathic Parkinson’s disease? Scand J Infect Dis 42, 604–608 (2010)
Alvarado-Esquivel C , Méndez-Hernández EM, Salas-Pacheco JM, Ruano-Calderón LÁ, Hernández-Tinoco J, Arias-Carrión O, Sánchez-Anguiano LF, Castellanos-Juárez FX, Sandoval-Carrillo AA, Liesenfeld O, Ramos-Nevárez A: Toxoplasma gondii exposure and Parkinson’s disease: a case-control study. BMJ Open. 7, e013019 (2017)
Perry CE , Gale SD, Erickson L, Wilson E, Nielsen B, Kauwe J, Hedges DW: Seroprevalence and serointensity of latent Toxoplasma gondii in a sample of elderly adults with and without Alzheimer Disease. Alzheimer Dis Assoc Disord 30, 123–126 (2016)
Alvarado-Esquivel C , Estrada-Martínez S, Pizarro-Villalobos H, Arce-Quiñones M, Liesenfeld O, Dubey JP: Seroepidemiology of Toxoplasma gondii infection in general population in a northern Mexican city. J Parasitol 97, 40–43 (2011)
Alvarado-Esquivel C , Mercado-Suarez MF, Rodríguez-Briones A, Fallad-Torres L, Ayala-Ayala JO, Nevarez-Piedra LJ, Duran-Morales E, Estrada-Martínez S, Liesenfeld O, Márquez-Conde JA, Martínez-García SA: Sero epidemiology of infection with Toxoplasma gondii in healthy blood donors of Durango, Mexico. BMC Infect Dis 7, 75 (2007)
Alvarado-Esquivel C , Sánchez-Anguiano LF, Hernández-Tinoco J, Arreola-Cháidez E, López J, Salcido-Meraz KI, Estrada-Martínez S, Navarrete-Flores JA, Pérez-Álamos AR, Hernández-Ochoa M, Rábago-Sánchez E, Liesenfeld O: High seroprevalence of Toxoplasma gondii infection in female sex workers: a case-control study. Eur J Microbiol Immunol (Bp) 5, 285–292 (2015)
Alvarado-Esquivel C , Hernández-Tinoco J, Sánchez-Anguiano LF, Ramos-Nevárez A, Cerrillo-Soto SM, Sáenz-Soto L, Liesenfeld O: High seroprevalence of Toxoplasma gondii infection in inmates: a case control study in Durango City, Mexico. Eur J Microbiol Immunol (Bp) 4, 76–82 (2014)
Alvarado-Esquivel C , Liesenfeld O, Márquez-Conde JA, Cisneros-Camacho A, Estrada-Martínez S, Martínez-García SA, González-Herrera A, García-Corral N: Seroepidemiology of infection with Toxoplasma gondii in waste pickers and waste workers in Durango, Mexico. Zoonoses Public Health 55, 306–312 (2008)
Alvarado-Esquivel C , Alanis-Quiñones OP, Arreola-Valenzuela MA, Rodríguez-Briones A, Piedra-Nevarez LJ, Duran-Morales E, Estrada-Martínez S, Martínez-García SA, Liesenfeld O: Seroepidemiology of Toxoplasma gondii infection in psychiatric inpatients in a northern Mexican city. BMC Infect Dis 6, 178 (2006)
Stock AK , Heintschel von Heinegg E, Köhling HL, Beste C: Latent Toxoplasma gondii infection leads to improved action control. Brain Behav Immun 37, 103–108 (2014)
Ene L , Marcotte TD, Umlauf A, Grancea C, Temereanca A, Bharti A, Achim CL, Letendre S, Ruta SM: Latent toxoplasmosis is associated with neurocognitive impairment in young adults with and without chronic HIV infection. J Neuroimmunol 299, 1–7 (2016)
Mendy A , Vieira ER, Albatineh AN, Gasana J: Toxoplasma gondii seropositivity and cognitive functions in schoolaged children. Parasitology 142, 1221–1227 (2015)
Mendy A , Vieira ER, Albatineh AN, Gasana J: Immediate rather than delayed memory impairment in older adults with latent toxoplasmosis. Brain Behav Immun 45, 36–40 (2015)
Gajewski PD , Falkenstein M, Hengstler JG, Golka K: Toxoplasma gondii impairs memory in infected seniors. Brain Behav Immun 36, 193–199 (2014)
Gajewski PD , Falkenstein M, Hengstler JG, Golka K: Reduced ERPs and theta oscillations underlie working memory deficits in Toxoplasma gondii infected seniors. Biol Psychol 120, 35–45 (2016)
Möhle L , Israel N, Paarmann K, Krohn M, Pietkiewicz S, Müller A, Lavrik IN, Buguliskis JS, Schott BH, Schlüter D, Gundelfinger ED, Montag D, Seifert U, Pahnke J, Dunay IR: Chronic Toxoplasma gondii infection enhances β-amyloid phagocytosis and clearance by recruited monocytes. Acta Neuropathol Commun 4, 25 (2016)
Wohlfert EA , Blader IJ, Wilson E. H. Brains and Brawn: Toxoplasma infections of the central nervous system and skeletal muscle. Trends Parasitol 33, 519–531 (2017)
Tedford E , McConkey G: Neurophysiological changes induced by chronic Toxoplasma gondii infection. Pathogens 6, E19 (2017)
Wang ZT , Harmon S, O’Malley KL, Sibley LD: Reassessment of the role of aromatic amino acid hydroxylases and the effect of infection by Toxoplasma gondii on host dopamine. Infect Immun 83, 1039–1047 (2015)
Ihara F , Nishimura M, Muroi Y, Mahmoud ME, Yokoyama N, Nagamune K, Nishikawa Y: Toxoplasma gondii Infection in mice impairs long-term fear memory consolidation through dysfunction of the cortex and amygdala. Infect Immun 84, 2861–2870 (2016)
Tanaka S , Nishimura M, Ihara F, Yamagishi J, Suzuki Y, Nishikawa Y: Transcriptome analysis of mouse brain infected with Toxoplasma gondii. Infect Immun 81, 3609–3619 (2013)
Ngô HM , Zhou Y, Lorenzi H, Wang K, Kim TK, Zhou Y, Bissati KE, Mui E, Fraczek L, Rajagopala SV, Roberts CW, Henriquez FL, Montpetit A, Blackwell JM, Jamieson SE, Wheeler K, Begeman IJ, Naranjo-Galvis C, Alliey-Rodriguez N, Davis RG, Soroceanu L, Cobbs C, Steindler DA, Boyer K, Noble AG, Swisher CN, Heydemann PT, Rabiah P, Withers S, Soteropoulos P, Hood L, McLeod R: Toxoplasma modulates signature pathways of human epilepsy, neurodegeneration & cancer. Sci Rep 7, 11496 (2017)